News

Interview

Tom Kirkwood: Aging is neither inevitable nor necessary

Features Innovation

Startup boasts multiple novel compounds with potential to halt progress of age-related disease

COVID-19: Leading clinician calls for focus on the biology of aging

Biotech Clinical trials Development Drugs Features Indication expansion

SyndicateRoom co-founder joins First Longevity

Investment Investment

Longevity investment: Apollo aims for the moon

Biotech Cellular Development Drugs Investment Investment Mitochondria Senescence Senolytic drugs

Leading academic “profoundly disappointed” by COVID-19 response

Biotech Drugs Economy Investment Senescence

Exclusive interview: Professor Richard Faragher and cellular senescence

Biotech Development Drugs Senescence Senolytic drugs Telomeres

VC enters Longevity market with K4Connect deal

Agetech Independent living Investment

New 3D bio-ink start-up targets neural tissue

3D Bio-printing Innovation Tissue/Organ

Find us here ...

© Copyright 2022 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.